27P Association between CD8+ tumor infiltrating lymphocytes and the clinical outcome of patients with operable breast cancer treated with adjuvant dose-dense chemotherapy: A 10-year follow up report of a Hellenic Cooperative Oncology Group observational study

N Spathas ,E Razis,Charisios Karanikiotis ,George Zarkavelis ,Helena Linardou ,Eleni Res ,Eleni Galani ,Emmanouil Saloustros ,Dimitrios Pectasides ,Helen Gogas ,M Bobos ,Amanda Psyrri ,Flora Zagouri ,G.-A Koliou ,Gerasimos Aravantinos ,Anna Klinke ,Angelos Koutras ,A Goussia ,D Bafaloukos ,George Fountzilas

doi:10.1016/j.annonc.2022.03.042

27P Association between CD8+ tumor infiltrating lymphocytes and the clinical outcome of patients with operable breast cancer treated with adjuvant dose-dense chemotherapy: A 10-year follow up report of a Hellenic Cooperative Oncology Group observational study

N Spathas , E Razis + Show 18 more

https://doi.org/10.1016/j.annonc.2022.03.042

Copy DOI

Journal: Annals of Oncology

Publication Date: May 1, 2022

Affiliation: Hellenic Cooperative Oncology Group

#Tumor-infiltrating Lymphocytes #Adjuvant Dose-dense Chemotherapy + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Tumor-infiltrating lymphocytes (TILs) and their subsets contribute to breast cancer prognosis. We investigated the prognostic impact of CD8+ TILs in patients with early intermediate/high-risk breast cancer treated with adjuvant anthracycline-based chemotherapy.

Full Text